Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study

被引：9
作者：
Overcast, Wynton B. [1 ]
Zhang, Jianying [2 ]
Zynger, Debra L. [3 ]
Tozbikian, Gary H. [3 ]
机构：
[1] Ohio State Univ, Coll Med, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, 320 Lincoln Tower,1800 Cannon Dr, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Wexner Med Ctr, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷 / 02期
关键词：
ASCO/CAP guidelines; Breast cancer; Equivocal category; HER2 immunohistochemistry (IHC); HER2 fluorescence in situ hybridization (FISH); IN-SITU HYBRIDIZATION; POLYMERASE CHAIN-REACTION; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; COPY NUMBER; CANCER; RECEPTOR; IMMUNOHISTOCHEMISTRY; TRASTUZUMAB; FISH;
D O I：
10.1007/s00428-016-1951-8
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 212
页数：10
相关论文
共 50 条
  • [31] Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
    Singh, Kamaljeet
    Tantravahi, Umadevi
    Lomme, Michele M.
    Pasquariello, Terese
    Steinhoff, Margaret
    Sung, C. James
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 405 - 411
  • [32] HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma
    Purdie, Colin A.
    Jordan, Lee B.
    McCullough, Jean B.
    Edwards, Sharon L.
    Cunningham, Joan
    Walsh, Miriam
    Grant, Andrew
    Pratt, Norman
    Thompson, Alastair M.
    HISTOPATHOLOGY, 2010, 56 (06) : 702 - 707
  • [33] The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines
    Yang, Libo
    Chen, Min
    Pu, Tianjie
    Wu, Shuang
    Wei, Bing
    Yang, Jieliang
    Bu, Hong
    Zhang, Zhang
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (05) : 283 - 290
  • [34] Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+by immunohistochemistry
    Taylor, Valerie J.
    Barnes, Penny J.
    Godwin, Sean C.
    Bethune, Gillian C.
    VIRCHOWS ARCHIV, 2021, 479 (01) : 23 - 31
  • [35] Indian Data on HER2 Fluorescence In Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As Per 2018 ASCO/CAP Guidelines
    Nagarjun, B. R.
    Parikh, Biren
    Patel, Manaswi Nareshkumar
    Trivedi, Pina J.
    Patel, Dharmesh M.
    SOUTH ASIAN JOURNAL OF CANCER, 2022, 11 (04) : 281 - 286
  • [36] HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma
    Perron, Marjorie
    Wen, Hannah Y.
    Hanna, Matthew G.
    Brogi, Edi
    Ross, Dara S.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (08) : 979 - 987
  • [37] HER2 ASCO guidelines. The answer to everything?
    Burandt, E.
    Sauter, G.
    PATHOLOGE, 2010, 31 : 285 - 291
  • [38] Effect of High Copy Number of HER2 Associated With Polysomy 17 on HER2 Protein Expression in Invasive Breast Carcinoma
    Shah, Sejal S.
    Wang, Yan
    Tull, Jamie
    Zhang, Shengle
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2009, 18 (01) : 30 - 33
  • [39] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
    Press, Michael F.
    Seoane, Jose A.
    Curtis, Christina
    Quinaux, Emmanuel
    Guzman, Roberta
    Sauter, Guido
    Eiermann, Wolfgang
    Mackey, John R.
    Robert, Nicholas
    Pienkowski, Tadeusz
    Crown, John
    Martin, Miguel
    Valero, Vicente
    Bee, Valerie
    Ma, Yanling
    Villalobos, Ivonne
    Slamon, Dennis J.
    JAMA ONCOLOGY, 2019, 5 (03) : 366 - 375
  • [40] UPDATE OF THE RECOMMENDATIONS FOR HER2 STATUS DETERMINATION IN BREAST CANCERS: ASCO/CAP 2013 AND GEFPICS 2014.
    Chahdi, H.
    Allaoui, M.
    Boudhas, A.
    Tbouda, M.
    El Ochi, M. R.
    Damiri, A.
    Al Bouzidi, A.
    Oukabli, M.
    JOURNAL OF MEDICAL AND SURGICAL RESEARCH, 2016, 3 (02): : 265 - 266
12345